Glutathione
LongevityEndogenous tripeptide antioxidantExperimental
Endogenous antioxidant tripeptide sold as an oral supplement and used IV in clinics. Not FDA-approved as a standalone drug for systemic โdetoxโ or skin-lightening claims.
For research use only.
Key Facts
- CAS
- 70-18-8
- Molecular Weight (MW)
- 307.32 g/mol
- Half-life
- ~1.5 hours (IV); oral bioavailability limited
- Unit
- mg
- Administration Route
- Oral, Subcutaneous, Intramuscular, or IV
- Frequency
- 1-3x weekly (injectable) or daily (oral)
- Last updated
- 8/23/2026
- Targets
- Reactive oxygen speciesGlutathione peroxidase
Overview
Endogenous antioxidant tripeptide sold as an oral supplement and used IV in clinics. Not FDA-approved as a standalone drug for systemic โdetoxโ or skin-lightening claims.
Protocol
- Dosage Range
- 250-2000 mg depending on route
- Frequency
- 1-3x weekly (injectable) or daily (oral)
- Cycle
- 4-12 weeks common; varies by research context
- Administration Route
- Oral, Subcutaneous, Intramuscular, or IV
- Reconstitution Guide
- Commonly reconstituted with bacteriostatic water for research use
May vary by vendor concentration and protocol.
Science
Mechanism of Action
Major intracellular thiol buffer; cofactor for glutathione peroxidases and GST enzymes. Oral bioavailability of reduced GSH is limited; IV use bypasses the gut.
Targets
Reactive oxygen speciesGlutathione peroxidase
Studies
- Glutathione biochemistry reviewโ Journal/year not available
Benefits
Redox-buffer researchSupplement and compounding use
Potential Side Effects
- IV: asthma-like reactions rare
- Abdominal cramps (oral)
References
- PMID 16139284External link ยท Year โ
- PubChem GSHExternal link ยท Year โ